- PackSize
- 50ug/100ug
- Target
- --
- Reactivity
- Human
- Applications
- ELISA, Bioactivity: FACS, Functional assay, Research in vivo
- Host Species
- Humanized
- Isotype
- IgG1-kappa
- Conjugate/Modification
- --
- Recommended Dilution Ratio
- --
- Composition
- 0.01M PBS, pH 7.4.
- Purification Process
- Protein A/G purified from cell culture supernatant.
- Purity
- >95% as determined by SDS-PAGE.
- storageCondition
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
- Clonality
- Monoclonal
- Clone Number
- --
- Immunogen
- Mammalian Cells
- Alias
- T-cell growth factor P40, Cytokine P40, IL9, Interleukin-9, IL-9
- Species
- --
- Gene ID-1
- P15248
- Uniprot
- --
- Background
- Enokizumab (MEDI-528) is a monoclonal antibody targeting to interleukin (IL)-9. IL-9 regulates the development of airway inflammation, mucus production, airway hyperresponsiveness, and airway fibrosis largely by increasing mast cell numbers and activity in the airways.<br>• IL-9 secreted by leukemia stem cells induces Th1-skewed CD4+ T cells, which promote their expansion., PMID:38941612<br/>• Positive feedback loop PU.1-IL9 in Th9 promotes rheumatoid arthritis development., PMID:39164066<br/>• The Role of Interleukin-9 in Cancer., PMID:31016637<br/>• IL-9, a local growth factor for synovial T cells in inflammatory arthritis., PMID:26751012<br/>• Locus of (IL-9) control: IL9 epigenetic regulation in cellular function and human disease., PMID:38825637<br/>• Interleukin-9 and mast cells., PMID:23034251<br/>• IL-9 sensitizes human T<sub>H</sub>2 cells to proinflammatory IL-18 signals in atopic dermatitis., PMID:39521283<br/>• IL-9 and IL-9-producing cells in tumor immunity., PMID:32228589<br/>• Interleukin-9 and T helper type 9 cells in rheumatic diseases., PMID:27159882<br/>• IL-9-producing T cells: potential players in allergy and cancer., PMID:32788707<br/>
- Tissue Expression
- --
- Signaling_pathway
- --
- Research Areas
- --